<DOC>
	<DOCNO>NCT00277550</DOCNO>
	<brief_summary>To demonstrate effect tegaserod gastrointestinal scintigraphic orocecal transit female patient CC upper GI symptom dyspepsia</brief_summary>
	<brief_title>The Effects Tegaserod v . Placebo Whole Gut Transit Time Patients With Chronic Constipation Dyspepsia</brief_title>
	<detailed_description />
	<mesh_term>Constipation</mesh_term>
	<mesh_term>Dyspepsia</mesh_term>
	<mesh_term>Tegaserod</mesh_term>
	<criteria>Females age 18 64 year age Patients must present two follow criterion chronic constipation least 12 week prior enter study : 1 . Less 3 bowel movement per week 2 . Hard lumpy stool 3 . Straining bowel movement 4 . Feeling incomplete evacuation Patients must report overlap symptom consistent dyspepsia , midupper abdominal discomfort characterize early satiety , postmeal fullness bloating Patients recent history , current frequency diarrhea occur per month laxative Clinically significant diagnosis pelvic outlet obstruction pelvic floor dyssenergia determine study physician Patients constipation secondary medication use determine study physician Patients clinically significant abnormal TSH level screen Patients heartburn abdominal pain predominant GI symptom Evidence cathartic colon history laxative abuse Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Constipation , Tegaserod , Dyspepsia</keyword>
</DOC>